{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "10",
                "@timestamp": "2022-02-10T06:04:09.000009-05:00",
                "@year": "2022",
                "@month": "02"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Ratchadapiseksompotch Fund"},
                {
                    "xocs:funding-agency-matched-string": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-agency-acronym": "MDCU",
                    "xocs:funding-agency": "Faculty of Medicine, Chulalongkorn University",
                    "xocs:funding-id": "RA64/015",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004776",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2021-11-13T23:12:27.805Z",
            "xocs:funding-text": "This work was supported by the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University, under Grant number RA64/015. This study was approved from the institute ethic committee No.258/63. The institutional review board chief committee is Emeritus Professor Tada Sueblinvong, MD.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Clinical Research for Holistic Management in Pediatric Hematology and Oncology"},
                                {"$": "Department of Pediatrics"},
                                {"$": "Faculty of Medicine"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60028190",
                                    "@dptid": "104425637"
                                },
                                {"@afid": "60022183"}
                            ],
                            "@affiliation-instance-id": "2015364858-1f9230ccbf673e6becbecab42d4409a7",
                            "ce:source-text": "Clinical Research for Holistic Management in Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "104425637"
                        },
                        "author": [
                            {
                                "ce:given-name": "Phumin",
                                "preferred-name": {
                                    "ce:given-name": "Phumin",
                                    "ce:initials": "P.",
                                    "ce:surname": "Chaweephisal",
                                    "ce:indexed-name": "Chaweephisal P."
                                },
                                "@author-instance-id": "2015364858-caeacc233efac51c83cbd95799367ea6",
                                "@seq": "1",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chaweephisal",
                                "@auid": "57204097565",
                                "ce:indexed-name": "Chaweephisal P."
                            },
                            {
                                "ce:given-name": "Aphinya",
                                "preferred-name": {
                                    "ce:given-name": "Aphinya",
                                    "ce:initials": "A.",
                                    "ce:surname": "Suroengrit",
                                    "ce:indexed-name": "Suroengrit A."
                                },
                                "@author-instance-id": "2015364858-5e2d3950b751a503d23ecb10d4949c4d",
                                "@seq": "3",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Suroengrit",
                                "@auid": "57190839750",
                                "ce:indexed-name": "Suroengrit A."
                            },
                            {
                                "ce:given-name": "Pattramon",
                                "preferred-name": {
                                    "ce:given-name": "Pattramon",
                                    "ce:initials": "P.",
                                    "ce:surname": "Aungbamnet",
                                    "ce:indexed-name": "Aungbamnet P."
                                },
                                "@author-instance-id": "2015364858-69157258b9ed577f794487b6af7a7c24",
                                "@seq": "4",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Aungbamnet",
                                "@auid": "54966685700",
                                "ce:indexed-name": "Aungbamnet P."
                            },
                            {
                                "ce:given-name": "Panya",
                                "preferred-name": {
                                    "ce:given-name": "Panya",
                                    "ce:initials": "P.",
                                    "ce:surname": "Seksarn",
                                    "ce:indexed-name": "Seksarn P."
                                },
                                "@author-instance-id": "2015364858-bb4083a8e81fc693ce6f57347a89a618",
                                "@seq": "5",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Seksarn",
                                "@auid": "6602786209",
                                "ce:indexed-name": "Seksarn P."
                            },
                            {
                                "ce:given-name": "Darintr",
                                "preferred-name": {
                                    "ce:given-name": "Darintr",
                                    "ce:initials": "D.",
                                    "ce:surname": "Sosothikul",
                                    "ce:indexed-name": "Sosothikul D."
                                },
                                "@author-instance-id": "2015364858-105e3ebde61aa2091bc64185a2943fa6",
                                "@seq": "6",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sosothikul",
                                "@auid": "15830686100",
                                "ce:indexed-name": "Sosothikul D."
                            },
                            {
                                "ce:given-name": "Supanun",
                                "preferred-name": {
                                    "ce:given-name": "Supanun",
                                    "ce:initials": "S.",
                                    "ce:surname": "Lauhasurayotin",
                                    "ce:indexed-name": "Lauhasurayotin S."
                                },
                                "@author-instance-id": "2015364858-1395af56418c98827e1599404e87074b",
                                "@seq": "7",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Lauhasurayotin",
                                "@auid": "57193696575",
                                "ce:indexed-name": "Lauhasurayotin S."
                            },
                            {
                                "ce:given-name": "Kanhatai",
                                "preferred-name": {
                                    "ce:given-name": "Kanhatai",
                                    "ce:initials": "K.",
                                    "ce:surname": "Chiengthong",
                                    "ce:indexed-name": "Chiengthong K."
                                },
                                "@author-instance-id": "2015364858-ff01f768ab03d93a266054a5e58678c1",
                                "@seq": "8",
                                "ce:initials": "K.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Chiengthong",
                                "@auid": "15519055800",
                                "ce:indexed-name": "Chiengthong K."
                            },
                            {
                                "ce:given-name": "Hansamon",
                                "preferred-name": {
                                    "ce:given-name": "Hansamon",
                                    "ce:initials": "H.",
                                    "ce:surname": "Poparn",
                                    "ce:indexed-name": "Poparn H."
                                },
                                "@author-instance-id": "2015364858-c2399bd4839e30c94ebcbdcc0c8ba2d9",
                                "@seq": "9",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Poparn",
                                "@auid": "57220779048",
                                "ce:indexed-name": "Poparn H."
                            },
                            {
                                "ce:given-name": "Piti",
                                "preferred-name": {
                                    "ce:given-name": "Piti",
                                    "ce:initials": "P.",
                                    "ce:surname": "Techavichit",
                                    "ce:indexed-name": "Techavichit P."
                                },
                                "@author-instance-id": "2015364858-651d1dd3a9374f877cd532a060757332",
                                "@seq": "10",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Techavichit",
                                "@auid": "57015326100",
                                "ce:indexed-name": "Techavichit P."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "organization": [
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "108180929"
                            },
                            "@affiliation-instance-id": "2015364858-3ce1a64a9a3aa60c270401006486cc13",
                            "ce:source-text": "Faculty of Pharmaceutical Sciences, Chulalongkorn University, Thailand",
                            "@dptid": "108180929"
                        },
                        "author": [{
                            "ce:given-name": "Trai",
                            "preferred-name": {
                                "ce:given-name": "Trai",
                                "ce:initials": "T.",
                                "ce:surname": "Tharnpanich",
                                "ce:indexed-name": "Tharnpanich T."
                            },
                            "@author-instance-id": "2015364858-4d46ac617bc9132f2eaebf45999467de",
                            "@seq": "2",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tharnpanich",
                            "@auid": "57194089205",
                            "ce:indexed-name": "Tharnpanich T."
                        }]
                    }
                ],
                "citation-title": "A Pharmacokinetic Study of Native E.coli Asparaginase for Acute Lymphoblastic Leukemia Treated with ThaiPOG Protocol",
                "abstracts": "© 2021. All Rights Reserved.Background: Asparaginase is one of the essential chemotherapies used to treat acute lymphoblastic leukemia (ALL). Asparaginase antibody production may cause a subtherapeutic level and result in an inferior outcome. The aim of this study was to prove the efficacy of current native E.coli asparaginase-based protocol. Moreover, does subtherapeutic result appeared in small group of the trial?. Methods: A prospective study of asparaginase activity among patients who received native E.coli asparaginase 10,000 IU/m2 intramuscularly according to The Thai Pediatric Oncology Group (ThaiPOG) protocol was done. The plasma asparaginase activity was measured by the coupled enzymatic reaction. Pharmacokinetic data including peak activity (Cmax), time to maximum concentration (Tmax), area under the curve (AUC0-48h) being elucidated. Results: Eight patients (five males and three females), median age 9.5 years, were enrolled. The median asparaginase activity of seven cases who were eligible for calculation reached Tmax within 24 hours (range 6-48 hours) with mean±SD of Cmax 3.60±0.34 (range 3.02-4.11) IU/ml. Mean±SD of AUC0-48h is 143.23±36.94 IU.h/mL (range 71.07 \u2013 180.12 IU.h/mL). The post-48-hour activity showed a mean±SD of 3.19±0.24 IU/ml (range 2.77-3.51 IU/ml) which implied an adequacy of activity over 48 hours and proper for the 12-day period. One relapsed ALL patient showed an extremely low AUC of asparaginase activity which coincided with urticaria after asparaginase injection. Subsequently, the asparaginase antibody was demonstrated in this patient. Conclusion: Native E. coli asparaginase-based protocol provides a compelling pharmacokinetic effect. Asparaginase activity and/or antibody testing is recommended for all cases especially in a relapsed patient, history of high accumulative dose of asparaginase or suspected allergic reaction. Patients with low asparaginase activity or allergy may benefit from switching to an alternative form of asparaginase to maintain treatment efficacy.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Clinical Research for Holistic Management in Pediatric Hematology and Oncology"},
                            {"$": "Department of Pediatrics"},
                            {"$": "Faculty of Medicine"},
                            {"$": "King Chulalongkorn Memorial Hospital"},
                            {"$": "Chulalongkorn University"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Piti",
                        "ce:initials": "P.",
                        "ce:surname": "Techavichit",
                        "ce:indexed-name": "Techavichit P."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "allergy",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "asparaginase",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Native",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "pharmacokinetic",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "silent inactivation",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Asian Pac. J. Cancer Preven.",
                    "website": {"ce:e-address": {
                        "$": "http://journal.waocp.org/?_action=article&vol=3118&issue=3124&max_rows=100",
                        "@type": "email"
                    }},
                    "@country": "tha",
                    "translated-sourcetitle": {
                        "$": "Asian Pacific Journal of Cancer Prevention",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "2476762X",
                            "@type": "electronic"
                        },
                        {
                            "$": "15137368",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "22",
                            "@issue": "10"
                        },
                        "pagerange": {
                            "@first": "3309",
                            "@last": "3315"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Asian Pacific Organization for Cancer Prevention"},
                    "sourcetitle": "Asian Pacific Journal of Cancer Prevention",
                    "@srcid": "40173",
                    "publicationdate": {
                        "year": "2021",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2021"
                        }
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2713"},
                                {"$": "2730"},
                                {"$": "2739"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": [
                                {"$": "MEDI"},
                                {"$": "BIOC"}
                            ]
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": {
                                "cas-registry-number": [
                                    {"$": "9015-68-3"},
                                    {"$": "1349719-22-7"}
                                ],
                                "enzyme-commission-number": "EC 3.5.1.1",
                                "chemical-name": "asparaginase"
                            }
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antibodies"},
                                {"chemical-name": "Antineoplastic Agents"},
                                {"chemical-name": "Asparaginase"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This work was supported by the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University, under Grant number RA64/015. This study was approved from the institute ethic committee No.258/63. The institutional review board chief committee is Emeritus Professor Tada Sueblinvong, MD.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNEMB"},
                    {"$": "Scopusbase"},
                    {"$": "MEDL"}
                ],
                "history": {"date-created": {
                    "@day": "13",
                    "@timestamp": "BST 08:29:07",
                    "@year": "2021",
                    "@month": "11"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2015364858",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "936695670",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "2021492068",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20214608828",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20213781262",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2021168787",
                            "@idtype": "SNEMB"
                        },
                        {
                            "$": "20219018203618",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85118801915",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85118801915",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "636642017",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "34711008",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "79419699",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.31557/APJCP.2021.22.10.3309"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "25",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Albertsen BK, Schroder H, Jakobsen P, et al (2001). Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries. Br J Clin Pharmacol, 52, 433-7.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2001"},
                            "ref-title": {"ref-titletext": "Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0034796838",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "52"},
                                "pagerange": {
                                    "@first": "433",
                                    "@last": "437"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BK",
                                        "@_fa": "true",
                                        "ce:surname": "Albertsen",
                                        "ce:indexed-name": "Albertsen BK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Schroder",
                                        "ce:indexed-name": "Schroder H"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Jakobsen",
                                        "ce:indexed-name": "Jakobsen P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Br J Clin Pharmacol"
                        },
                        "ce:source-text": "Albertsen BK, Schroder H, Jakobsen P, et al (2001). Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries. Br J Clin Pharmacol, 52, 433-7."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Asselin BL (2011). L-asparaginase for treatment of childhood acute lymphoblastic leukemia: what have we learned?. Pediatr Blood Cancer, 57, 357-8.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "L-asparaginase for treatment of childhood acute lymphoblastic leukemia: what have we learned?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79960181113",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "57"},
                                "pagerange": {
                                    "@first": "357",
                                    "@last": "358"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "BL",
                                "@_fa": "true",
                                "ce:surname": "Asselin",
                                "ce:indexed-name": "Asselin BL"
                            }]},
                            "ref-sourcetitle": "Pediatr Blood Cancer"
                        },
                        "ce:source-text": "Asselin BL (2011). L-asparaginase for treatment of childhood acute lymphoblastic leukemia: what have we learned?. Pediatr Blood Cancer, 57, 357-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Avramis VI, Sencer S, Periclou AP, et al (2002). A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children\u2019s Cancer Group study. Blood, 99, 1986-94.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children\u2019s Cancer Group study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037085747",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "99"},
                                "pagerange": {
                                    "@first": "1986",
                                    "@last": "1994"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "VI",
                                        "@_fa": "true",
                                        "ce:surname": "Avramis",
                                        "ce:indexed-name": "Avramis VI"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Sencer",
                                        "ce:indexed-name": "Sencer S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AP",
                                        "@_fa": "true",
                                        "ce:surname": "Periclou",
                                        "ce:indexed-name": "Periclou AP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Avramis VI, Sencer S, Periclou AP, et al (2002). A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children\u2019s Cancer Group study. Blood, 99, 1986-94."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Avramis VA, Sencer S, Periclou AP, et al (2002). A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children\u2019s Cancer Group study. Blood, 99.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2002"},
                            "ref-title": {"ref-titletext": "A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children\u2019s Cancer Group study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0037085747",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {"voliss": {"@volume": "99"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "VA",
                                        "@_fa": "true",
                                        "ce:surname": "Avramis",
                                        "ce:indexed-name": "Avramis VA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Sencer",
                                        "ce:indexed-name": "Sencer S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AP",
                                        "@_fa": "true",
                                        "ce:surname": "Periclou",
                                        "ce:indexed-name": "Periclou AP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Avramis VA, Sencer S, Periclou AP, et al (2002). A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children\u2019s Cancer Group study. Blood, 99."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bidwell SS, Peterson CC, Demanelis K, et al (2019). Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011. Pediatr Blood Cancer, 66, e27428.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85056803678",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "66"},
                                "pagerange": {"@first": "e27428"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SS",
                                        "@_fa": "true",
                                        "ce:surname": "Bidwell",
                                        "ce:indexed-name": "Bidwell SS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CC",
                                        "@_fa": "true",
                                        "ce:surname": "Peterson",
                                        "ce:indexed-name": "Peterson CC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Demanelis",
                                        "ce:indexed-name": "Demanelis K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pediatr Blood Cancer"
                        },
                        "ce:source-text": "Bidwell SS, Peterson CC, Demanelis K, et al (2019). Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011. Pediatr Blood Cancer, 66, e27428."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Brueck M, Koerholz D, Nuernberger W, et al (1989). Elimination of l-asparaginase in children treated for acute lymphoblastic leukemia. Dev Pharmacol Ther, 12, 200-4.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1989"},
                            "ref-title": {"ref-titletext": "Elimination of l-asparaginase in children treated for acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0024360501",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "200",
                                    "@last": "204"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Brueck",
                                        "ce:indexed-name": "Brueck M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Koerholz",
                                        "ce:indexed-name": "Koerholz D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Nuernberger",
                                        "ce:indexed-name": "Nuernberger W"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Dev Pharmacol Ther"
                        },
                        "ce:source-text": "Brueck M, Koerholz D, Nuernberger W, et al (1989). Elimination of l-asparaginase in children treated for acute lymphoblastic leukemia. Dev Pharmacol Ther, 12, 200-4."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cecconello DK, Werlang ICR, AlegrettiAP, et al (2018). \u2018Monitoring asparaginase activity in middle-income countries. Lancet Oncol, 19, 1149-50.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Monitoring asparaginase activity in middle-income countries"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85055660727",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "1149",
                                    "@last": "1150"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DK",
                                        "@_fa": "true",
                                        "ce:surname": "Cecconello",
                                        "ce:indexed-name": "Cecconello DK"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "ICR",
                                        "@_fa": "true",
                                        "ce:surname": "Werlang",
                                        "ce:indexed-name": "Werlang ICR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AP",
                                        "@_fa": "true",
                                        "ce:surname": "Alegretti",
                                        "ce:indexed-name": "Alegretti AP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Cecconello DK, Werlang ICR, AlegrettiAP, et al (2018). \u2018Monitoring asparaginase activity in middle-income countries. Lancet Oncol, 19, 1149-50."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Children\u2019s Oncology Group (2015a). \u2018AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia or Localized B-lineage Lymphoblastic Lymphoma\u2019. https://childrensoncologygroup.org/aall0932.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://childrensoncologygroup.org/aall0932",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85118788692",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Children\u2019s Oncology Group (a)",
                            "ref-sourcetitle": "AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia or Localized B-lineage Lymphoblastic Lymphoma"
                        },
                        "ce:source-text": "Children\u2019s Oncology Group (2015a). \u2018AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia or Localized B-lineage Lymphoblastic Lymphoma\u2019. https://childrensoncologygroup.org/aall0932."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Children\u2019s Oncology Group (2015b). \u2018AALL1131: A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Including a Stratum Evaluating Dasatinib in Patients with Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations\u2019. https://childrensoncologygroup.org/AALL1131.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://childrensoncologygroup.org/AALL1131",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85118772986",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Children\u2019s Oncology Group (b)",
                            "ref-sourcetitle": "AALL1131: A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Including a Stratum Evaluating Dasatinib in Patients with Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations"
                        },
                        "ce:source-text": "Children\u2019s Oncology Group (2015b). \u2018AALL1131: A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Including a Stratum Evaluating Dasatinib in Patients with Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations\u2019. https://childrensoncologygroup.org/AALL1131."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Dinndorf PA, Gootenberg J, Cohen MH, Keegan P, Pazdur R (2007). FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). Oncologist, 12, 991-8.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34548392267",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "991",
                                    "@last": "998"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "PA",
                                    "@_fa": "true",
                                    "ce:surname": "Dinndorf",
                                    "ce:indexed-name": "Dinndorf PA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Gootenberg",
                                    "ce:indexed-name": "Gootenberg J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MH",
                                    "@_fa": "true",
                                    "ce:surname": "Cohen",
                                    "ce:indexed-name": "Cohen MH"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Keegan",
                                    "ce:indexed-name": "Keegan P"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Pazdur",
                                    "ce:indexed-name": "Pazdur R"
                                }
                            ]},
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Dinndorf PA, Gootenberg J, Cohen MH, Keegan P, Pazdur R (2007). FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). Oncologist, 12, 991-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Egler RA, Ahuja SP, Matloub Y (2016). L-asparaginase in the treatment of patients with acute lymphoblastic leukemia. J Pharmacol Pharmacother, 7, 62-71.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "L-asparaginase in the treatment of patients with acute lymphoblastic leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84978115939",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "62",
                                    "@last": "71"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RA",
                                    "@_fa": "true",
                                    "ce:surname": "Egler",
                                    "ce:indexed-name": "Egler RA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "SP",
                                    "@_fa": "true",
                                    "ce:surname": "Ahuja",
                                    "ce:indexed-name": "Ahuja SP"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Matloub",
                                    "ce:indexed-name": "Matloub Y"
                                }
                            ]},
                            "ref-sourcetitle": "J Pharmacol Pharmacother"
                        },
                        "ce:source-text": "Egler RA, Ahuja SP, Matloub Y (2016). L-asparaginase in the treatment of patients with acute lymphoblastic leukemia. J Pharmacol Pharmacother, 7, 62-71."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ho DH, Whitecar JP, Luce JK, Frei E (1970). L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow. Cancer Res, 30, 466-72.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1970"},
                            "ref-title": {"ref-titletext": "L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0014741232",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "466",
                                    "@last": "472"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DH",
                                    "@_fa": "true",
                                    "ce:surname": "Ho",
                                    "ce:indexed-name": "Ho DH"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JP",
                                    "@_fa": "true",
                                    "ce:surname": "Whitecar",
                                    "ce:indexed-name": "Whitecar JP"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "JK",
                                    "@_fa": "true",
                                    "ce:surname": "Luce",
                                    "ce:indexed-name": "Luce JK"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Frei",
                                    "ce:indexed-name": "Frei E"
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Ho DH, Whitecar JP, Luce JK, Frei E (1970). L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow. Cancer Res, 30, 466-72."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ho DH, Yap HY, Brown N, et al (1981). Clinical pharmacology of intramuscularly administered L-asparaginase. J Clin Pharmacol, 21, 72-8.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1981"},
                            "ref-title": {"ref-titletext": "Clinical pharmacology of intramuscularly administered L-asparaginase"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0019532588",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "72",
                                    "@last": "78"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DH",
                                        "@_fa": "true",
                                        "ce:surname": "Ho",
                                        "ce:indexed-name": "Ho DH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "HY",
                                        "@_fa": "true",
                                        "ce:surname": "Yap",
                                        "ce:indexed-name": "Yap HY"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Brown",
                                        "ce:indexed-name": "Brown N"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Pharmacol"
                        },
                        "ce:source-text": "Ho DH, Yap HY, Brown N, et al (1981). Clinical pharmacology of intramuscularly administered L-asparaginase. J Clin Pharmacol, 21, 72-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Katz AJ, Chia VM, Schoonen WM, Kelsh MA (2015). Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden. Cancer Causes Control, 26, 1627-42.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84943365686",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "1627",
                                    "@last": "1642"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AJ",
                                    "@_fa": "true",
                                    "ce:surname": "Katz",
                                    "ce:indexed-name": "Katz AJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "VM",
                                    "@_fa": "true",
                                    "ce:surname": "Chia",
                                    "ce:indexed-name": "Chia VM"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "WM",
                                    "@_fa": "true",
                                    "ce:surname": "Schoonen",
                                    "ce:indexed-name": "Schoonen WM"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "MA",
                                    "@_fa": "true",
                                    "ce:surname": "Kelsh",
                                    "ce:indexed-name": "Kelsh MA"
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Causes Control"
                        },
                        "ce:source-text": "Katz AJ, Chia VM, Schoonen WM, Kelsh MA (2015). Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden. Cancer Causes Control, 26, 1627-42."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Lexicomp Online Database [database on the Internet] (2021). \u2018Asparaginase (E. coli)\u2019. https://www.uptodate.com/drug-interactions/?source=responsive_home#di-analyze.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.uptodate.com/drug-interactions/?source=responsive_home#di-analyze",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85118766513",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Lexicomp Online Database [database on the Internet]",
                            "ref-sourcetitle": "Asparaginase (E. coli)"
                        },
                        "ce:source-text": "Lexicomp Online Database [database on the Internet] (2021). \u2018Asparaginase (E. coli)\u2019. https://www.uptodate.com/drug-interactions/?source=responsive_home#di-analyze."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Metayer LE, Brown RD, Carlebur S, Burke GAA, Brown GC (2019). Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts. Apoptosis, 24, 145-56.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85058953169",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "145",
                                    "@last": "156"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "LE",
                                    "@_fa": "true",
                                    "ce:surname": "Metayer",
                                    "ce:indexed-name": "Metayer LE"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "RD",
                                    "@_fa": "true",
                                    "ce:surname": "Brown",
                                    "ce:indexed-name": "Brown RD"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Carlebur",
                                    "ce:indexed-name": "Carlebur S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "GAA",
                                    "@_fa": "true",
                                    "ce:surname": "Burke",
                                    "ce:indexed-name": "Burke GAA"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "GC",
                                    "@_fa": "true",
                                    "ce:surname": "Brown",
                                    "ce:indexed-name": "Brown GC"
                                }
                            ]},
                            "ref-sourcetitle": "Apoptosis"
                        },
                        "ce:source-text": "Metayer LE, Brown RD, Carlebur S, Burke GAA, Brown GC (2019). Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts. Apoptosis, 24, 145-56."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ortega JA, Nesbit ME, J Donaldson MH, et al (1977). \u2018L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res, 37, 535-40.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1977"},
                            "ref-title": {"ref-titletext": "L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0017360242",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "535",
                                    "@last": "540"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JA",
                                        "@_fa": "true",
                                        "ce:surname": "Ortega",
                                        "ce:indexed-name": "Ortega JA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "ME",
                                        "@_fa": "true",
                                        "ce:surname": "Nesbit",
                                        "ce:indexed-name": "Nesbit ME"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MH",
                                        "@_fa": "true",
                                        "ce:surname": "Donaldson",
                                        "ce:indexed-name": "Donaldson MH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Ortega JA, Nesbit ME, J Donaldson MH, et al (1977). \u2018L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia. Cancer Res, 37, 535-40."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Pinheiro JP, Boos J (2004). The best way to use asparaginase in childhood acute lymphatic leukaemia\u2013still to be defined?\u2019. Br J Haematol, 125, 117-27.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "The best way to use asparaginase in childhood acute lymphatic leukaemia\u2013still to be defined?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "2042503031",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "125"},
                                "pagerange": {
                                    "@first": "117",
                                    "@last": "127"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JP",
                                    "@_fa": "true",
                                    "ce:surname": "Pinheiro",
                                    "ce:indexed-name": "Pinheiro JP"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Boos",
                                    "ce:indexed-name": "Boos J"
                                }
                            ]},
                            "ref-sourcetitle": "Br J Haematol"
                        },
                        "ce:source-text": "Pinheiro JP, Boos J (2004). The best way to use asparaginase in childhood acute lymphatic leukaemia\u2013still to be defined?\u2019. Br J Haematol, 125, 117-27."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Riccardi R, Holcenberg JS, Glaubiger DL, Wood JH, Poplack DG (1981). L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res, 41, 4554-8.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1981"},
                            "ref-title": {"ref-titletext": "L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0019778519",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "4554",
                                    "@last": "4558"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Riccardi",
                                    "ce:indexed-name": "Riccardi R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JS",
                                    "@_fa": "true",
                                    "ce:surname": "Holcenberg",
                                    "ce:indexed-name": "Holcenberg JS"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "DL",
                                    "@_fa": "true",
                                    "ce:surname": "Glaubiger",
                                    "ce:indexed-name": "Glaubiger DL"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "JH",
                                    "@_fa": "true",
                                    "ce:surname": "Wood",
                                    "ce:indexed-name": "Wood JH"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "DG",
                                    "@_fa": "true",
                                    "ce:surname": "Poplack",
                                    "ce:indexed-name": "Poplack DG"
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Riccardi R, Holcenberg JS, Glaubiger DL, Wood JH, Poplack DG (1981). L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res, 41, 4554-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Salzer WL, Asselin B, Supko JG, et al (2013). Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children\u2019s Oncology Group\u2019. Blood, 122, 507-14.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children\u2019s Oncology Group"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84886925289",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "122"},
                                "pagerange": {
                                    "@first": "507",
                                    "@last": "514"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "WL",
                                        "@_fa": "true",
                                        "ce:surname": "Salzer",
                                        "ce:indexed-name": "Salzer WL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Asselin",
                                        "ce:indexed-name": "Asselin B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JG",
                                        "@_fa": "true",
                                        "ce:surname": "Supko",
                                        "ce:indexed-name": "Supko JG"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Salzer WL, Asselin B, Supko JG, et al (2013). Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children\u2019s Oncology Group\u2019. Blood, 122, 507-14."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "The Thai Pediatric Oncology Group (2018). National protocol for the treatment of childhood cancers 2018 (bangkok).",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85118787393",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "The Thai Pediatric Oncology Group",
                            "ref-sourcetitle": "National protocol for the treatment of childhood cancers 2018 (bangkok)"
                        },
                        "ce:source-text": "The Thai Pediatric Oncology Group (2018). National protocol for the treatment of childhood cancers 2018 (bangkok)."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Van der Sluis IM, Vrooman LM, Pieters R, et al (2016). Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation. Haematologica, 101, 279-85.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84959275822",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "101"},
                                "pagerange": {
                                    "@first": "279",
                                    "@last": "285"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "IM",
                                        "@_fa": "true",
                                        "ce:surname": "Van der Sluis",
                                        "ce:indexed-name": "Van der Sluis IM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "LM",
                                        "@_fa": "true",
                                        "ce:surname": "Vrooman",
                                        "ce:indexed-name": "Vrooman LM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Pieters",
                                        "ce:indexed-name": "Pieters R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Haematologica"
                        },
                        "ce:source-text": "Van der Sluis IM, Vrooman LM, Pieters R, et al (2016). Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation. Haematologica, 101, 279-85."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Walenciak J, Wyka K, Janczar S, Mlynarski W, Zalewska-Szewczyk B (2019). Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment. Pharmacol Rep, 71, 311-8.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85062153841",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "71"},
                                "pagerange": {
                                    "@first": "311",
                                    "@last": "318"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Walenciak",
                                    "ce:indexed-name": "Walenciak J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Wyka",
                                    "ce:indexed-name": "Wyka K"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Janczar",
                                    "ce:indexed-name": "Janczar S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "W",
                                    "@_fa": "true",
                                    "ce:surname": "Mlynarski",
                                    "ce:indexed-name": "Mlynarski W"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Zalewska-Szewczyk",
                                    "ce:indexed-name": "Zalewska-Szewczyk B"
                                }
                            ]},
                            "ref-sourcetitle": "Pharmacol Rep"
                        },
                        "ce:source-text": "Walenciak J, Wyka K, Janczar S, Mlynarski W, Zalewska-Szewczyk B (2019). Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment. Pharmacol Rep, 71, 311-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Wang B, Relling MV, Storm MC, et al (2003). Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia, 17, 1583-8.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0041520550",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "1583",
                                    "@last": "1588"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MV",
                                        "@_fa": "true",
                                        "ce:surname": "Relling",
                                        "ce:indexed-name": "Relling MV"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MC",
                                        "@_fa": "true",
                                        "ce:surname": "Storm",
                                        "ce:indexed-name": "Storm MC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Leukemia"
                        },
                        "ce:source-text": "Wang B, Relling MV, Storm MC, et al (2003). Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients. Leukemia, 17, 1583-8."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Wetzler M, Sanford BL, Kurtzberg J, et al (2007). Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511. Blood, 109, 4164-7.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34248325307",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "109"},
                                "pagerange": {
                                    "@first": "4164",
                                    "@last": "4167"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Wetzler",
                                        "ce:indexed-name": "Wetzler M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "BL",
                                        "@_fa": "true",
                                        "ce:surname": "Sanford",
                                        "ce:indexed-name": "Sanford BL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Kurtzberg",
                                        "ce:indexed-name": "Kurtzberg J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Blood"
                        },
                        "ce:source-text": "Wetzler M, Sanford BL, Kurtzberg J, et al (2007). Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511. Blood, 109, 4164-7."
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85118801915",
        "dc:description": "Background: Asparaginase is one of the essential chemotherapies used to treat acute lymphoblastic leukemia (ALL). Asparaginase antibody production may cause a subtherapeutic level and result in an inferior outcome. The aim of this study was to prove the efficacy of current native E.coli asparaginase-based protocol. Moreover, does subtherapeutic result appeared in small group of the trial?. Methods: A prospective study of asparaginase activity among patients who received native E.coli asparaginase 10,000 IU/m2 intramuscularly according to The Thai Pediatric Oncology Group (ThaiPOG) protocol was done. The plasma asparaginase activity was measured by the coupled enzymatic reaction. Pharmacokinetic data including peak activity (Cmax), time to maximum concentration (Tmax), area under the curve (AUC0-48h) being elucidated. Results: Eight patients (five males and three females), median age 9.5 years, were enrolled. The median asparaginase activity of seven cases who were eligible for calculation reached Tmax within 24 hours (range 6-48 hours) with mean±SD of Cmax 3.60±0.34 (range 3.02-4.11) IU/ml. Mean±SD of AUC0-48h is 143.23±36.94 IU.h/mL (range 71.07 \u2013 180.12 IU.h/mL). The post-48-hour activity showed a mean±SD of 3.19±0.24 IU/ml (range 2.77-3.51 IU/ml) which implied an adequacy of activity over 48 hours and proper for the 12-day period. One relapsed ALL patient showed an extremely low AUC of asparaginase activity which coincided with urticaria after asparaginase injection. Subsequently, the asparaginase antibody was demonstrated in this patient. Conclusion: Native E. coli asparaginase-based protocol provides a compelling pharmacokinetic effect. Asparaginase activity and/or antibody testing is recommended for all cases especially in a relapsed patient, history of high accumulative dose of asparaginase or suspected allergic reaction. Patients with low asparaginase activity or allergy may benefit from switching to an alternative form of asparaginase to maintain treatment efficacy.",
        "pubmed-id": "34711008",
        "prism:coverDate": "2021-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85118801915",
        "dc:creator": {"author": [{
            "ce:given-name": "Phumin",
            "preferred-name": {
                "ce:given-name": "Phumin",
                "ce:initials": "P.",
                "ce:surname": "Chaweephisal",
                "ce:indexed-name": "Chaweephisal P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Chaweephisal",
            "@auid": "57204097565",
            "author-url": "https://api.elsevier.com/content/author/author_id/57204097565",
            "ce:indexed-name": "Chaweephisal P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85118801915"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85118801915&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85118801915&origin=inward"
            }
        ],
        "source-id": "40173",
        "citedby-count": "0",
        "prism:volume": "22",
        "subtype": "ar",
        "dc:title": "A Pharmacokinetic Study of Native E.coli Asparaginase for Acute Lymphoblastic Leukemia Treated with ThaiPOG Protocol",
        "openaccess": "1",
        "prism:issn": "2476762X 15137368",
        "publishercopyright": "© 2021. All Rights Reserved.",
        "prism:issueIdentifier": "10",
        "subtypeDescription": "Article",
        "prism:publicationName": "Asian Pacific Journal of Cancer Prevention",
        "prism:pageRange": "3309-3315",
        "prism:endingPage": "3315",
        "openaccessFlag": "true",
        "prism:doi": "10.31557/APJCP.2021.22.10.3309",
        "prism:startingPage": "3309",
        "dc:identifier": "SCOPUS_ID:85118801915",
        "dc:publisher": "Asian Pacific Organization for Cancer Prevention"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Antibodies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antineoplastic Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Area Under Curve",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Asparaginase",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Child",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Child, Preschool",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Escherichia coli",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Infant",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Injections, Intramuscular",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Prospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Time Factors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Urticaria",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "allergy"
        },
        {
            "@_fa": "true",
            "$": "asparaginase"
        },
        {
            "@_fa": "true",
            "$": "Native"
        },
        {
            "@_fa": "true",
            "$": "pharmacokinetic"
        },
        {
            "@_fa": "true",
            "$": "silent inactivation"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Phumin",
            "preferred-name": {
                "ce:given-name": "Phumin",
                "ce:initials": "P.",
                "ce:surname": "Chaweephisal",
                "ce:indexed-name": "Chaweephisal P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Chaweephisal",
            "@auid": "57204097565",
            "author-url": "https://api.elsevier.com/content/author/author_id/57204097565",
            "ce:indexed-name": "Chaweephisal P."
        },
        {
            "ce:given-name": "Trai",
            "preferred-name": {
                "ce:given-name": "Trai",
                "ce:initials": "T.",
                "ce:surname": "Tharnpanich",
                "ce:indexed-name": "Tharnpanich T."
            },
            "@seq": "2",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Tharnpanich",
            "@auid": "57194089205",
            "author-url": "https://api.elsevier.com/content/author/author_id/57194089205",
            "ce:indexed-name": "Tharnpanich T."
        },
        {
            "ce:given-name": "Aphinya",
            "preferred-name": {
                "ce:given-name": "Aphinya",
                "ce:initials": "A.",
                "ce:surname": "Suroengrit",
                "ce:indexed-name": "Suroengrit A."
            },
            "@seq": "3",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Suroengrit",
            "@auid": "57190839750",
            "author-url": "https://api.elsevier.com/content/author/author_id/57190839750",
            "ce:indexed-name": "Suroengrit A."
        },
        {
            "ce:given-name": "Pattramon",
            "preferred-name": {
                "ce:given-name": "Pattramon",
                "ce:initials": "P.",
                "ce:surname": "Aungbamnet",
                "ce:indexed-name": "Aungbamnet P."
            },
            "@seq": "4",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Aungbamnet",
            "@auid": "54966685700",
            "author-url": "https://api.elsevier.com/content/author/author_id/54966685700",
            "ce:indexed-name": "Aungbamnet P."
        },
        {
            "ce:given-name": "Panya",
            "preferred-name": {
                "ce:given-name": "Panya",
                "ce:initials": "P.",
                "ce:surname": "Seksarn",
                "ce:indexed-name": "Seksarn P."
            },
            "@seq": "5",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Seksarn",
            "@auid": "6602786209",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602786209",
            "ce:indexed-name": "Seksarn P."
        },
        {
            "ce:given-name": "Darintr",
            "preferred-name": {
                "ce:given-name": "Darintr",
                "ce:initials": "D.",
                "ce:surname": "Sosothikul",
                "ce:indexed-name": "Sosothikul D."
            },
            "@seq": "6",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Sosothikul",
            "@auid": "15830686100",
            "author-url": "https://api.elsevier.com/content/author/author_id/15830686100",
            "ce:indexed-name": "Sosothikul D."
        },
        {
            "ce:given-name": "Supanun",
            "preferred-name": {
                "ce:given-name": "Supanun",
                "ce:initials": "S.",
                "ce:surname": "Lauhasurayotin",
                "ce:indexed-name": "Lauhasurayotin S."
            },
            "@seq": "7",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Lauhasurayotin",
            "@auid": "57193696575",
            "author-url": "https://api.elsevier.com/content/author/author_id/57193696575",
            "ce:indexed-name": "Lauhasurayotin S."
        },
        {
            "ce:given-name": "Kanhatai",
            "preferred-name": {
                "ce:given-name": "Kanhatai",
                "ce:initials": "K.",
                "ce:surname": "Chiengthong",
                "ce:indexed-name": "Chiengthong K."
            },
            "@seq": "8",
            "ce:initials": "K.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Chiengthong",
            "@auid": "15519055800",
            "author-url": "https://api.elsevier.com/content/author/author_id/15519055800",
            "ce:indexed-name": "Chiengthong K."
        },
        {
            "ce:given-name": "Hansamon",
            "preferred-name": {
                "ce:given-name": "Hansamon",
                "ce:initials": "H.",
                "ce:surname": "Poparn",
                "ce:indexed-name": "Poparn H."
            },
            "@seq": "9",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Poparn",
            "@auid": "57220779048",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220779048",
            "ce:indexed-name": "Poparn H."
        },
        {
            "ce:given-name": "Piti",
            "preferred-name": {
                "ce:given-name": "Piti",
                "ce:initials": "P.",
                "ce:surname": "Techavichit",
                "ce:indexed-name": "Techavichit P."
            },
            "@seq": "10",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Techavichit",
            "@auid": "57015326100",
            "author-url": "https://api.elsevier.com/content/author/author_id/57015326100",
            "ce:indexed-name": "Techavichit P."
        }
    ]}
}}